Prostate Cancer Clinical Trials in Uniondale, New York

8 studies are recruiting for prostate cancer in Uniondale, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer

    In this study the investigators will find out whether the use of a new type of boost approach called irreversible electroporation (IRE) is as effective as the standard boost approach of radiation therapy for participants with intermediate-risk prostate cancer receiving standard stereotactic body ra…

    Stage
    Phase 3
    Ages
    Any age
    Site
    Memorial Sloan Kettering at Nassau (Limited Protocol Activities), Uniondale, New York
    Locations
    8 in total
    Run by
    Memorial Sloan Kettering Cancer Center
  2. A Study of Changes to Prostate Procedures

    The purpose of this study is to look whether using local anesthesia during a transperineal prostate biopsy, while put to sleep by IV sedation, helps reduce the number of people who feel significant pain in the recovery room. The researchers will also look at how local anesthesia affects the amount …

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Nassau (Consent Only), Uniondale, New York
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center
  3. [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer

    This study will use PET scans, which is a type of x-ray test that uses a radiotracer, to see whether these scans may be better able to find places in the body where your prostate cancer may have spread.

    Stage
    Not phased
    Ages
    Any age
    Site
    Memorial Sloan Kettering Nassau (Consent Only), Uniondale, New York
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center
  4. Researching the Effect of Exercise on Cancer

    Researchers think that exercise may be able to prevent cancer from coming back by lowering ctDNA levels. The purpose of this study is to explore how aerobic exercise (exercise that stimulates and strengthens the heart and lungs and improves the body's use of oxygen) can reduce the level of ctDNA fo…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York
    Locations
    9 in total
    Run by
    City of Hope Medical Center
  5. This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

    This study will explore whether a combination of the investigational drug mevrometostat (PF-06821497) and enzalutamide will work better than taking enzalutamide alone in participants with mCSPC who are ARPI naïve and have not yet received chemotherapy in the mCSPC setting.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    MSK Nassau., Uniondale, New York
    Locations
    337 in total
    Run by
    Pfizer
  6. MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

    Many people with cancer spend a lot of time and money traveling to and from the doctor's office for cancer care. MSK's goal is to make getting cancer care easier by cutting down the need to make in-person visits to MSK. MSK is trying to do this through a new option called enhanced telehealth.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale, New York
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center
  7. A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

    The purpose of this study is to find out whether tinengotinib in combination with abiraterone acetate and prednisone or enzalutamide is a safe treatment that causes few or mild side effects in people with metastatic castration-resistant prostate cancer (mCRPC).

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York
    Locations
    12 in total
    Run by
    Memorial Sloan Kettering Cancer Center
  8. A Study of Lower Dose Radiation Therapy for People With Prostate Cancer

    The purpose of this study is to see whether giving a lower (de-escalated) dose of radiation therapy to some parts of the prostate can reduce side effects compared to giving the same (uniform) dose of radiation therapy to the whole prostate.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Memorial Sloan Kettering at Nassau (Limited Protocol Activities), Uniondale, New York
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.